Back to ANRO

Affinity Asset Advisors, LLC → ANRO

Affinity Asset Advisors, LLC ANRO Position History

Alto Neuroscience, Inc. • Healthcare

Quarters held
3
Latest value
$16.4M
Q3 2026
Peak value
$22.4M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$11.2M
Q2 2026$22.4M
Q3 2026$16.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$16.4M643.3K——
Q2 2026$22.4M850.0K——
Q1 2026$11.2M500.0K——

Other funds holding ANRO

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M